Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies

Merck

Market Cap: Mex$199.2b

Operates as a healthcare company worldwide.

Regeneron Pharmaceuticals

Market Cap: Mex$59.3b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Viatris

Market Cap: Mex$9.0b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Royalty Pharma

Market Cap: Mex$18.4b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Teva Pharmaceutical Industries

Market Cap: Mex$15.4b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Bayer

Market Cap: Mex$19.8b

Operates as a life science company worldwide.

IQVIA Holdings

Market Cap: Mex$25.7b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

CSPC Pharmaceutical Group

Market Cap: Mex$69.4b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, North America, Europe, and internationally.

Vaxart

Market Cap: Mex$117.4m

A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform.

CureVac

Market Cap: Mex$715.6m

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Incyte

Market Cap: Mex$11.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

GSK

Market Cap: Mex$52.5b

Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Pfizer

Market Cap: Mex$124.3b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Novo Nordisk

Market Cap: Mex$1.9t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Genomma Lab Internacional. de

Market Cap: Mex$22.2b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

Novartis

Market Cap: Mex$163.4b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

Organon

Market Cap: Mex$2.9b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Exact Sciences

Market Cap: Mex$8.3b

Provides cancer screening and diagnostic test products in the United States and internationally.

Novavax

Market Cap: Mex$942.5m

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

Zai Lab

Market Cap: Mex$3.2b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Perrigo

Market Cap: Mex$3.7b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Halozyme Therapeutics

Market Cap: Mex$5.2b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

BeiGene

Market Cap: Mex$14.0b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Jazz Pharmaceuticals

Market Cap: Mex$6.1b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

CRISPR Therapeutics

Market Cap: Mex$3.4b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Novo Nordisk

Market Cap: Mex$1.9t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Ipsen

Market Cap: Mex$9.2b

Operates as a biopharmaceutical company worldwide.

Elanco Animal Health

Market Cap: Mex$4.3b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Gilead Sciences

Market Cap: Mex$129.1b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Sarepta Therapeutics

Market Cap: Mex$5.0b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

ACADIA Pharmaceuticals

Market Cap: Mex$3.8b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Astellas Pharma

Market Cap: Mex$2.8t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

Biogen

Market Cap: Mex$16.9b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Ardelyx

Market Cap: Mex$1.1b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Bristol-Myers Squibb

Market Cap: Mex$103.2b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Atossa Therapeutics

Market Cap: Mex$83.5m

Operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States.